A novel immunostimulatory OX40/PD-L1 bivalent bispecific antibody (MEDI1109) for the treatment of patients with cancer

被引：2

作者：

Oberst, Michael D. ^{[1
]}

Kasturirangan, Srinath ^{[1
]}

Sachs, Clifford ^{[1
]}

Auge, Catherine ^{[1
]}

Moynihan, James ^{[1
]}

Rothstein, Raymond ^{[1
]}

Hair, James ^{[2
]}

Neal, Francis ^{[2
]}

Mamidi, Srinivas ^{[2
]}

Hanabuchi, Shino ^{[1
]}

Watkins, Amanda ^{[2
]}

Zheng, Yanan ^{[3
]}

Rosenthal, Kim ^{[1
]}

Freeman, Daniel J. ^{[1
]}

Hammond, Scott ^{[1
]}

机构：

[1] MedImmune, Gaithersburg, MD USA

[2] MedImmune, Liverpool, Merseyside, England

[3] MedImmune, San Francisco, CA USA

来源：

CANCER RESEARCH | 2018年 / 78卷 / 13期

关键词：

D O I：

10.1158/1538-7445.AM2018-2775

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2775

引用

页数：2

共 50 条

[31] Prognostic Role of OX40, LAG-3, TIM-3 and PD-L1 Expression in Bone and Soft Tissue Sarcomas [J].

Inci, Bediz Kurt ;

Acar, Elif ;

Gurler, Fatih ;

Ilhan, Ayseguel ;

Yildiz, Fatih ;

Ardic, Fisun ;

Oksuzoglu, Berna ;

Ozdemir, Nuriye ;

Ozet, Ahmet ;

Esendagli, Guldal ;

Yazici, Ozan .

JOURNAL OF CLINICAL MEDICINE, 2024, 13 (12)

[32] Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment [J].

Hiro Sato ;

Noriyuki Okonogi ;

Takashi Nakano .

International Journal of Clinical Oncology, 2020, 25 :801-809

[33] Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment [J].

Sato, Hiro ;

Okonogi, Noriyuki ;

Nakano, Takashi .

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (05) :801-809

[34] A phase Ib dose escalation study of the OX40 agonist MOXR0916 and the PD-L1 inhibitor atezolizumab in patients with advanced solid tumors. [J].

Infante, Jeffrey R. ;

Hansen, Aaron Richard ;

Pishvaian, Michael J. ;

Chow, Laura Quan Man ;

McArthur, Grant A. ;

Bauer, Todd Michael ;

Liu, Stephen V. ;

Sandhu, Shahneen Kaur ;

Tsai, Frank Yung -Chin ;

Kim, Jeong ;

Stefanich, Eric ;

Li, Chi -Chung ;

Gilber, Houston ;

Mccall, Bruce ;

Anderson, Maria S. ;

Huseni, Mahrukh ;

Rhee, Ina Park ;

Siu, Lillian L. ;

Gordon, Michael S. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)

[35] A novel bispecific antibody CVL006 superior to AK112 for dual targeting of PD-L1 and VEGF in cancer therapy [J].

Wang, Chunyan ;

Huang, Hao ;

Song, Zeng ;

Li, Zhongyuan ;

Huang, Jinwen ;

Cao, Liang ;

Wu, Ziai ;

Pan, Junfang ;

Chen, Xiaobing ;

Shen, Xiaokun .

ANTIBODY THERAPEUTICS, 2025, 8 (03) :189-196

[36] Anti-tumor effectiveness of a novel bispecific antibody that blocks both PD-L1 and LAG-3 [J].

Zhang, Chenxing ;

Liu, Jiaxin ;

Sun, Minglv ;

Gu, Tiejun ;

Meng, Xiangyu ;

Zhu, Shidong ;

Zhang, Youfeng ;

Wang, Linlin ;

Chen, Yan ;

Zhang, Daguang ;

Wu, Yongge .

MOLECULAR IMMUNOLOGY, 2025, 182 :30-40

[37] Preclinical evaluation of XB628: A novel PD-L1 x NKG2A bispecific antibody [J].

Sim, Bee-Cheng ;

Hammer, Bonnie ;

Pulukkunat, Dileep ;

Chen, Jing ;

Lee, Annika ;

Bercher, Mark ;

Li, Hanying ;

Higaki, Jeffrey ;

Ritter, Anna ;

Kantak, Seema .

CANCER RESEARCH, 2025, 85 (08)

[38] A phase 1 study of MEDI4736, an anti PD-L1 antibody, in patients with advanced solid tumors. [J].

Lutzky, Jose ;

Antonia, Scott Joseph ;

Blake-Haskins, Andy ;

Li, Xia ;

Robbins, Paul B. ;

Shaiabl, Aiman M. ;

Vasseill, Jim ;

Ibrahim, Ramy A. ;

Khleif, Samir ;

Segal, Neil Howard .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)

[39] Preclinical data of IAR037, a novel CD40/PD-L1 bispecific antibody for the treatment of advanced solid tumors resistant to immune checkpoint inhibitors Free [J].

Chen, Shi ;

Zhou, Shuaixiang ;

Xiong, Yao ;

Li, Li ;

Guo, Qian ;

Lei, Yucong ;

Zhang, Zhimin ;

Ni, Meng ;

Wu, Zhihai ;

Chen, Bingliang ;

He, Kaijie .

CANCER RESEARCH, 2025, 85 (08)

[40] Effect of cancer immunotherapy with CD39/PD-L1 bispecific antibody OriA631-b [J].

Li, Xiaopei ;

Zhang, Yuchen ;

Yang, Ze ;

Deng, Qi ;

Wang, Huajing ;

Zhu, Haiyan ;

Lu, Ligong ;

Li, Xian-Yang ;

Qu, Ryan ;

He, Xiaowen .

JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)

← 1 2 3 4 5 →